Cargando…
Risk of SARS-CoV-2 Reinfections in a Prospective Inception Cohort Study: Impact of COVID-19 Vaccination
The risk of reinfection could be related to the initial SARS-CoV-2 clinical presentation, but there are no data about the risk change after SARS-CoV-2 vaccination. We evaluated the rate of reinfection in an inception cohort study of 4943 health care workers (HCWs) according to symptoms and serologic...
Autores principales: | Casado, José L., Haemmerle, Johannes, Vizcarra, Pilar, Ramirez-Alonso, Gema, Salazar-Tosco, Andrea, Romero-Hernandez, Beatriz, Blasco, Magdalena, Rodriguez-Dominguez, Mario, Mirabella, Itria G., Vallejo, Alejandro, Fernandez-Escribano, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225121/ https://www.ncbi.nlm.nih.gov/pubmed/35743421 http://dx.doi.org/10.3390/jcm11123352 |
Ejemplares similares
-
mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection
por: Casado, José L., et al.
Publicado: (2023) -
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination
por: Casado, José L., et al.
Publicado: (2023) -
T‐cell response after first dose of BNT162b2 SARS‐CoV‐2 vaccine among healthcare workers with previous infection or cross‐reactive immunity
por: Casado, Jose L, et al.
Publicado: (2021) -
SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study
por: Casado, José L., et al.
Publicado: (2021) -
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
por: Vizcarra, Pilar, et al.
Publicado: (2021)